T Cell Immunotherapy for Multiple Myeloma Patients Undergoing a Bone Marrow Transplant
NCT00048464
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
35
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Myeloma
Interventions
PROCEDURE:
Infusion of Activated & Expanded Autologous T Cells
Sponsor
Xcyte Therapies